Jump to the Content

Jazz Pharmaceuticals Acquires Cavion, for Up To $312.5M

Jazz Pharmaceuticals plc (Nasdaq: JAZZ), a global biopharmaceutical company dedicated to developing life-changing medicines for people with limited or no options, acquired Cavion, Inc., a Charlottesville, VA and Cambridge, MA-based clinical-stage biotechnology company.

Under the terms of the deal, which was made possible through a merger with a Jazz subsidiary, the former Cavion shareholders receive an upfront

payment of $52.5m and have the potential to receive additional payments of up to $260.0m upon the achievement of certain clinical, regulatory and commercial milestones, for a total potential consideration of $312.5m.

Led by Andrew Krouse, president and chief executive officer, Cavion is a clinical-stage biotechnology company that creates therapies aimed at modulating the T-type calcium channel for the treatment of chronic and rare neurological diseases.

Its lead molecule, CX-8998, is a first-in-class T-type calcium channel modulator in development for essential tremor. It has been evaluated in a Phase 2 randomized, placebo-controlled clinical study in patients with essential tremor.
The study demonstrated proof-of-concept, supporting continued development of CX-8998 as a potential treatment for essential tremor.

Led by Robert Iannone, M.D., M.S.C.E., executive vice president, research and development, Jazz Pharmaceuticals is a leader in sleep medicine with a growing hematology/oncology portfolio. The company markets SunosiTM (solriamfetol), Xyrem® (sodium oxybate) oral solution, Defitelio® (defibrotide sodium), Erwinaze® (asparaginase Erwinia chrysanthemi) and Vyxeos® (daunorubicin and cytarabine) liposome for injection in the U.S. and markets Defitelio® (defibrotide), Erwinase® and Vyxeos® 44 mg/100 mg powder for concentrate for solution for infusion in countries outside the U.S.

Read the press release by FINSMES here

The CvilleBioHub was created to inform and connect the biotech and life sciences community, to provide pathways for growth and to promote the area as a center for this dynamic industry